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Abstract
Schistosomes are easily transmitted and high chance of repeat infection, so if control strategies based on
targeted mass drug administration (MDA) are to succeed it is essential to have a test that is sensitive, accurate
and simple to use. It is known and regularly demonstrated that praziquantel does not always eliminate an
infection so in spite of the successes of control programs a residual of the reservoir survives to re-infect snails.
The issue of diagnostic sensitivity becomes more critical in the assessment of program effectiveness.
While serology, such as antigen capture tests might improve sensitivity, it has been shown that the presence of
species-specific DNA fragments will indicate, most effectively, the presence of active parasites. Polymerase chain
reaction (PCR) can amplify and detect DNA from urine residuecaptured on Whatman No. 3 filter paper that is
dried after filtration. Previously we have detected S. mansoni and S. haematobium parasite-specific small repeat
DNA fragment from filtered urine on filter paper by PCR. In the current study, we assessed the efficacy of
detection of 86 urine samples for either or both schistosome parasites by PCR and loop-mediated isothermal
amplification (LAMP) that were collected from a low to moderate transmission area in Ghana. Two
different DNA extraction methods, standard extraction kit and field usable LAMP-PURE kit were also evaluated
by PCR and LAMP amplification. With S. haematobium LAMP amplification for both extractions showed similar
sensitivity and specificity when compared with PCR amplification (100%) verified by gel electrophoresis. For S.
mansoni sensitivity was highest for LAMP amplification (100%) for standard extraction than PCR and LAMP with
LAMP-PURE (99% and 94%). The LAMP-PURE extraction produced false negatives, which require further
investigation for this field usable extraction kit. Overall high positive and negative predictive values (90% −
100%) for both species demonstrated a highly robust approach. The LAMP approach is close to point of care use
and equally sensitive and specific to detection of species-specific DNA by PCR. LAMP can be an effective means
to detect low intensity infection due to its simplicity and minimal DNA extraction requirement. This will enhance
the effectiveness of surveillance and MDA control programs of schistosomiasis.
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1. Introduction
Point of care diagnosis is a priority for strategies that rely on mass drug administration (MDA) for the control of
many of the neglected tropical diseases(NTDs). As these strategies are applied and evaluated it is clear that the
use of signs such as hematuria for urinary schistosomiasis or examination of stool smears such as the Kato-Katz

(KK) test are unsatisfactory as diagnostics because of the lack of sensitivity (Lodh et al., 2013). Currently a point
of care test for Schistosoma mansoni, the circulating cathodic antigen (CCA) test is in use, but it is similar in
sensitivity as the KK smear in detecting S. mansoni and quite inadequate to detect S. haematobium infection
(Stothard et al., 2006). Recently, however, it has been shown at least with schistosomes, that fragments
of somatic DNA from both S. haematobiumand S. mansoni are detectable in urine (Ibironke et al., 2011), and can
be extracted from filter paper through which a urine specimen was filtered and dried and thus avoids the
collection and handling of stool specimens (Lodh et al., 2014). Although collecting and examining specimens has
been greatly improved by filtration of urine in the field, and examination in a central laboratory, there still
remains the need for thermocycler and electrophoresis equipment for the examination. These procedures can
be replaced in the field by the loop-mediated isothermal amplification (LAMP) technology (Abbasi et al., 2010).
Detection of parasite species-specific DNA in urine indicates the presence of the actual parasite even when eggs
or antigens are not always detectable, and schistosome DNA in urine has been shown to clear from infected
people by two weeks after praziquantel treatment (Ibironke et al., 2012). In a carefully controlled study from
Zambia, Lodh et al. (2013) showed that detecting S. mansoni species-specific DNA fragment in the urine
precipitate, there was a 30% disparity between CCA and PCR test. In China, (Xu et al., 2014) showed a six-fold
difference between the KK smear (performed nine times per sample) and Schistosoma japonicum specific DNA
detection from serum. Clearly it is important to add parasite species-specific DNA detection to the diagnostic
repertoire and keep the technology as close to the point of care as possible (Shiff, 2014). The LAMP procedure
commonly is made up from supplies obtainable from scientific vendors. It is highly specific as it uses four sets of
primers to amplify six target regions of the DNA (Notomi et al., 2000). It also amplifies DNA fragments
independent of the standard thermocycler and electrophoresis and can easily be adapted for clinical trials. The
procedure depends on extraction and purification of the target DNA. This can be done by use of the
standard DNA extraction kit (such as,QIAmpDNA Blood mini kit), or by other means of purification. The Eiken
Chemical Company, Japan have produced a LAMP-PURE (Procedure for Ultra Rapid Extraction) kit, which
incorporates a proprietary method for DNA extraction and purification in order to improve the sensitivity of the
amplification process. In this work, we compared PCR amplification of DNA extracted and purified with
QIAmpDNA Blood Mini kit against LAMP amplification of DNA extracted and purified with QIAmp and LAMPPURE to determine whether there was any advantage in diagnostic accuracy from 86 filtered urine specimens
collected from a community in southern Ghana. The objective of this study was to compare the efficacy of two
methods of extracting DNA from urine deposit on coarse filter paper (Whatman No 3.) dried after filtration and
stored at room temperature (Ibironke et al., 2011) and their effect on two different types of amplification.

2. Materials and methods
2.1. Study design and population
The study location and population had been described in detail in previous publication (Lodh et al., 2014).
Briefly, the study was carried out at Tomefa, a district of the greater Accra region in Ghana. Colleagues of the
Noguchi Memorial Institute for Medical Research (NMIMR) chose this area because of the presence of both S.
mansoni and S. haematobium and an ongoing study that focused on intestinal schistosomiasis for NMIMR. Stool
specimens for S. mansoni were examined using the KK method, but there was no urine examination for S.
haematobium. For this study, urine samples were collected from 86 participants between 5 and 23 years of age
specifically for DNA detection. Approval for the diagnostic research was provided by NMIMR (IRB: 043/12-13).
Written study consent was collected from parents or guardians in case of minors and from individuals in case of
18 years or older. Participants found infected parasitologically were treated by praziquantel by NMIMR and local
health centers.

Urine samples (approximately 40–50 mL) were collected between 10:00 am and 2:00 pm and were evaluated for
color, pH, and specific gravity and for presence of protein, glucose bilirubin and hematuria with Hemastix (Bayer,
Elkhart, IN). After physiological assessment, approximately 50 mL whole urine was filtered through Whatman
No. 3 filter paper (Whatman International, Maidstone, England), then dried under a fly-proof net and
individually packed in Ziploc bags with desiccant. Filter papers without any personal information and only with
number associated with specimen along with age, sex, physiological and diagnostic information were brought
back to Johns Hopkins School of Public Health, Baltimore, Maryland for molecular diagnosis. DNA was extracted
from urine sediment captured on filter paper by QIAmpDNA Blood Mini Kit (Qiagen, MD) and LAMP PURE kit
(Eiken Chemical Co., Ltd, Japan). DNA extracted by Qiagen kit was evaluated by both PCR and LAMP. LAMP PURE
kit extracted DNA was evaluated only by LAMP.

2.2. DNA extraction from urine by Qiagen and LAMP PURE kit
Each filter paper was folded to form a cone to drain the urine. DNA was extracted from marked inner quadrant
at the base of filter paper by QIAmpDNA Blood Mini Kit (Qiagen, MD, USA). From each quadrant 15 pieces of
∼1 mm diameter paper disc was punched off by a regular paper punch. After every use, the paper punch and
scissor was cleaned by 10% bleach solution and distilled water to avoid any contamination. All 15 paper discs for
each sample were placed in 1.5 mL Eppendorf tube with 600 μL nuclease-free water and heated at 95 °C for
10 min and then kept on a rotor at room temperature (22–25 °C) for 16–18 h. The next day water solution was
transferred to a Qiagen QIAmp 2 mL column tube and DNA was extracted by following manufacturer’s protocol.
The adjacent quadrant was used to extract DNA by LAMP-PURE kit. The PURE kit was consisted of a series of
extraction and purifying steps. Step 1: An aliquot of sample (water extract as described above) was heated at
90 °C for 10 min using a water bath to lyse any cellular material. This was added to the manufacturers DNA
extraction solution, mixed by inversion and incubated. Step 2: The sample was then treated
with adsorbent ingredient to remove inhibitory materials contained in the sample and to neutralize the solution
without any loss of the target DNA.
DNA concentration was measured using the NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies,
USA). Qiagen-kit-extracted DNA concentration was ranged from 1 to 10 ng/μL. PURE-kit-extracted DNA
concentration was ranged from 50 to 1200 ng/μL. Therefore, PURE-kit-extracted DNA was diluted at 1:10 ratio
as DNA concentration was too high for amplification.

2.3. PCR amplification for S. mansoni and S. haematobium
PCR amplification was carried out in 10 μL volume with positive and negative controls. For S. mansoni, KK
positives were used as positive control and for S. haematobium, hematuria and urine filtration positives were
used as positive control. Water was used as negative control for both parasite species. For PCR amplification, the
reaction volume consisted of 5 μL of PCR Master Mix, 2X (Promega, Madison, WI, USA), 0.5 μL (10 μM) of each
amplification primers, 1.5–2 μL of 25 mM MgCl2, 2 μL of DNA (concentration: 4–6 ng/μL) and rest nuclease-freewater. The amplification profile for S. mansoni was initial denaturation at 95 °C for 10 min and 35 cycles at 95 °C
for 30 s, 60 °C for 90 s, 72 °C for 30 s and a final extension at 72 °C for 5 min. For S. haematobium the denaturing
step was at 95 °C for 10 min, followed by 33 cycles of 95 °C for 30 s, 53 °C for 90 s, and 72 °C for 1 min, followed
by a final extension step at 60 °C for 5 min. To confirm amplification and correct ampliconsize, PCR products
were visualized in 2% agarose gel stained with ethidium bromide(10 mg/μL) with 50 bp DNA marker (New
England BioLabs Inc., Ipswich, MA, USA).
Eighty-six urine samples were investigated by PCR for both schistosome species DNA obtained from Qiagen
miniprep. For S. mansoni, PCR was carried out by amplifying 110 bp fragment from a highly repeated 121 bp
region of S. mansonidescribed by Hamburger (Hamburger et al., 1991). Primers for PCR amplification were

described by Pontes et al. (Pontes et al., 2002). For S. haematobium 121 bp Dra Irepeat fragment was amplified
by primers previously designed by Hamburger et al. (Hamburger et al., 2001). In case of both schistosome
species the repeat fragments comprise of 12–16% of each parasite genome (∼600,000 copies per cell) occur in
different region of genomes of these two schistosome parasites.

2.4. LAMP amplification for S. mansoni and S. haematobium
The LAMP ready-to-use buffer mix was prepared to do the LAMP amplification and was performed on two
separate DNA templates, one (labeled LAMP) was obtained with Qiagen Miniprep kit and the second (labeled
LAMP-PURE) was obtained with LAMP-PURE extraction and purification kit. The following procedures were
carried out. The buffer mix was composed of 2X concentration of the following reagents: 10X LAMP buffer
(Eiken Chemical Co., Ltd, Japan), 5 M Betaine (Sigma, St. Louis, MO), 10 mM dNTPs (Promega, Madison, WI).
Four μL of ready mix buffer was used for 10 μL LAMP reaction mix. Other than ready mix the reaction mix
contained 0.5 μL of LAMP primers (5 pmoles of F3 and B3 and 40 pmoles of FIP and BIP), 1 μL of Bst DNA
polymerase (Lucigen, Middleton, WI), 2 μL of extracted DNA and 0.5 μL nuclease free water. LAMP amplification
was for 2 h at 63 °C with inactivation for 5 min at 80 °C. Detection of LAMP products were performed by using
SYBR Green I stain (Life Technologies, Grand Island, NY) by adding 1 μL (1:20 dilution). To confirm correct
amplification, LAMP products were visualized in 2% agarose gel stained with ethidium bromide (10 mg/μL) and
run with 50 bp ladder (New England BioLabs Inc., Ipswich, MA). Details of primers were used, including the
internal species specific F3 and B3 as well as the loop FIB and BIP primers for each schistosome species were
given in Table 1.
Table 1. Primer sets used for species-specific DNA amplification of Schistosoma mansoni and S. haematobium by
LAMP and PCR methodsa.
Schistosome
parasite
Schistosoma
mansoni

Amplification
type
LAMP

Oligonucleotide
name
F3

Oligonucleotide sequence

Reference

5′ GAT CTG AAT CCG ACC AAC CG 3′

B3
FIP

Hamburger et
al., 2013

PCR

SmPF

5′ AAC GCC CAC GCT CTC GCA 3′
5′ AAA TCC GTC CAG TGG TTT TTT TGA
AAA TCG TTG TAT CTC CG 3′
5′ CCG AAA CCA CTG GAC GGA TTT TTA
TTT TTA ATC TAA AAC AAA CAT C 3′
5′ GAT CTG AAT CCG ACC AAC CG 3′

LAMP

SmPR
F3

5′ ATA TTA ACG CCC ACG CTC TC 3′
5′ GAT CTC ACC TAT CAG ACG 3′

B3
FIP

ShDra1F

5 5' GTC ACC AAT AAT ATG AAA C 3'
5′ CCA ACA ATT TTA AAT TTT ATC AGA
CGA AAC AAA GAA AAT 3′
5′ GGT CGT ATC GTT GTG AAA TTT TCA
CCA ATA ATA TGA AAC AAT 3'
5′ TCA CAA CGA TAC GAC CAA C 3′

ShDra1R
ShDra1R

5′ GAT CTC ACC TAT CAG ACG AAA C 3′
5′ TCA CAA CGA TAC GAC CAA C 3′

BIP

Schistosoma
haematobium

BIP
PCR

Pontes et al.,
2002
Hamburger et
al., 2013

Hamburger et
al., 2001
2001

LAMP = loop-mediated isothermal amplification; PCR = polymerase chain reaction; F3 = forward external
primer; B3 = backwards external primer; FIP = forward internal primer; BIP = backwards internal primer.
a

2.5. Statistical analyses
The analytical procedure was designed to compare two approaches of DNA amplification. Specificity and
sensitivity of urine-based DNA detection for diagnosis of current schistosome infections had been evaluated
(Lodh et al., 2014). Data generated in the study were evaluated quantitatively and qualitatively. Also, agreement
statistics, Bowker’s Symmetry (Anne and Sonja 2007) was calculated to determine the accuracy of the tests.
Bowker’s symmetry tested for lack of agreement between comparisons of two tests. Only numerical values
(1 = positive and 0 = negative) were used for statistical analysis. Data for S. mansoni were represented as PCR_S.
mansoni_QiaAmp kit, LAMP_S. mansoni_ QiaAmp kit, LAMP_S. mansoni_PURE kit, and for S. haematobium were
represented as PCR_S. haematobium_QiaAmp kit, LAMP_ S. haematobium_QiaAmp kit and LAMP_ S.
haematobium_PURE kit.
In this study PCR + was regarded as true positive and PCR − was regarded as true negative. Positivity and
negativity for LAMP amplification of Qiagen extracted DNA and PURE kit extracted DNA was determined based
on the PCR outcomes. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV)
was calculated using MedCalc 12.4.0 (MedCalc Software, Belgium). Agreement statistics, Bowker’s Symmetry
was calculated by JMP 9 (JMP® v9, SAS Institute Inc., Cary, North Carolina) to determine the agreement between
PCR and LAMP diagnostic tests.

2.6. Assessment of positive and negative cases
The results were analyzed as follows:
•
•
•
•

If KK+ then presence of infection confirmed for S. mansoni.
If PCR+ or LAMP+ (S. haematobium primers) presence of infection for S. haematobium.
If PCR+ or LAMP+ (S. mansoni primers) presence of infection for S. mansoni.
If both products were amplified from one specimen then presence of dual S. mansoni and S.
haematobium infection.

3. Results
3.1. Evaluation of PCR and LAMP
We found a large number of mixed S. mansoni/S.haematobium infections by both PCR and LAMP amplification
(Table 2). There were 72/86 S. haematobium and 81/86 S. mansoni with LAMP assay, whereas 21% false
negativity with the KK specimen exam. The LAMP-PURE for S. mansoni did not perform well as expected with
this parasite, showing 6% false negative. In supplementary material, two by two tables are presented for
comparison of the PCR and LAMP amplification methods and the two DNA extraction methods. Overall the
detection of S. haematobium using LAMP method is similar for both extraction and only two specimens were
missed by PCR amplified from Qiagen extracted DNA. The differences were not significant.
Table 2. Frequency of infected and uninfected people from Ghana for Schistosoma mansoni and S.
haematobium evaluated by polymerase chain reaction (PCR) and loop mediated isothermal amplification
(LAMP), where DNA was extracted by QiaAmp extraction kit and by LAMP-PURE kit.
Diagnostic Test
True Positive
False positive True Negative
False Negative
(TP)
(FP)
(TN)
(FN)
KKa_S. mansoni
57 (66%)
0
11 (13%)
18 (21%)
PCR_S. mansoni_QiaAmp kit
74 (86%)
0
11 (13%)
1 (1%)
LAMP_S. mansoni_QiaAmp kit
81 (94%)
0
5 (6%)
0
LAMP_S. mansoni_PURE kit
76 (88%)
0
5 (6%)
5 (6%)

Total
86
86
86
86

PCR_S. haematobium_QiaAmp
kit
LAMP_ S.
haematobium_QiaAmp kit
LAMP_ S. haematobium_PURE
kit
a
KK = Kato-Katz test.

70 (81%)

0

16 (19%)

0

86

72 (84%)

0

14 (16%)

0

86

72 (84%)

0

14 (16%)

0

86

3.2. Assessment of agreement statistics
Agreement statistics was calculated by comparing two above-mentioned molecular methods for both S.
mansoni and S. haematobium. Bowker’s symmetry calculated the level of disagreement between tests in 2-way
tables and the test decision was based on X2 approximation of the distribution of the test statistic (Anne and
Sonja, 2007). For S. mansoni, the Bowker Symmetry was significantly different from random (P < 0.05) for the
comparison between LAMP_QiaAmp and PCR and in case of LAMP_QiaAmp and LAMP_PURE, indicating that
test positives by LAMP_QiaAmp were highly unlikely to be the same with PCR and LAMP_PURE (Table 3). The
test agreement was significantly correlated for PCR and LAMP_PURE (0.33; Table 4). For S. haematobium, the
symmetry of disagreement was also significantly lower throughout for all comparisons (0 and 2), which indicated
that test positives by LAMP_QiaAmp are highly likely to be same with PCR and LAMP_PURE (Table 3).
Table 3. Estimation of Bowker symmetry index (Agreement Statistics) for two species-specific DNA
amplification methods and two DNA extraction methods.
Diagnostic Test

Bowker’s Symmetry test*
Symmetry of Disagreement
PCR_S. mansoni_QiaAmp kit vs. LAMP_S. mansoni_ QiaAmp kit
7
PCR_S. mansoni_QiaAmp kit vs LAMP_S. mansoni_PURE kit
0.33
LAMP_S. mansoni_ QiaAmp kit vs. LAMP_S. mansoni_PURE kit
5
PCR_S. haematobium_QiaAmp kit vs. LAMP_ S. haematobium_QiaAmp kit 2
PCR_S. haematobium_QiaAmp kit vs. LAMP_ S. haematobium_PURE kit
2
LAMP_ S. haematobium_QiaAmp kit vs. LAMP_ S. haematobium_PURE kit 0
*Bowker’s Symmetry test = this test checks for symmetry in 2-way tables and the test decision is based on
a X2 approximation of the distribution of the test statistic.
ψ
= α level was set at 0.05.
* = Significant.

P valueψ
0.0082*
0.5637
0.0253*
0.1573
0.1573
1.0000

4. Discussion
In the current study, LAMP was used for integrated diagnosis of single or mixed schistosome infection by
amplifying parasite species-specific DNA from urine samples. Recently our group successfully detected
schistosome parasite-specific DNA by PCR amplification in S. haematobium (Ibironke et al., 2011) and S.
mansoni(Lodh et al., 2013) individually and for both S. haematobium and S. mansoni (Lodh et al., 2014) from
urine sediment captured on filter paper through filtration. In all cases, our approach showed high sensitivity and
specificity with no cross-reactivity with other related helminthes. However, there is an added cost and
technological limitation involved for employing PCR based DNA detection in the field (Hamburger et al., 1991). A
simple molecular procedure adapted as a point of care diagnostic test to rural conditions is needed, and for this
we used LAMP technology.
In Africa the two human species of schistosomes, S. mansoni and S. haematobium are often concurrent in the
human population (Hotez and Fenwick, 2009). This sympatric distribution also raises the problem of accurate
and specific diagnosis of asymptomatic cases. It is important to remember that such cases can still infect
molluscan hosts and keep the transmission going. So these reservoirs of infection must be detected in order to

eliminate the risk of human re-infection. Sensitivity of microscopic examination decreases in older people so
that the relationship of each parasite with human morbidity is not evaluated (King and Dangerfield-Cha, 2008)
and this will affect disease treatment and any control effort (Booth et al., 2004, Ernould et al., 1999).
Differentiating between these species can be challenging, as it involves the examination of urine for egg or
antigen by dipstick or by CCA and stool for egg detection. Logistically and technically such tasks are time
consuming and as shown (Ibironke et al., 2011, Lodh et al., 2013) these procedures are inadequately sensitive
and produce false negative results. Active schistosome infections are normally diagnosed by demonstrating
parasite eggs in the excreta, however in chronic and low-intensity infections these eggs appear sporadically and
are difficult to detect. This is extremely critical with intestinal schistosomiasis when the standard method, the KK
technique uses only 50mg feces, some 1/10,000 of a normal fecal mass. This is particularly important when mass
chemotherapy programs are designed to reduce or eliminate foci of infection. For S. haematobium, the repeat
DNA detection in urine is superior in sensitivity and specificity to antigen capture, hematuria or ELISA detection
of antibody. WHO has drawn attention to the need for tests with high specificity but also improved sensitivity,
which can be applicable in the field. We have demonstrated that it is possible to detect DNA specific to both
schistosome parasites from a single source of urine, thus simplifying the collection and performance of tests that
are more sensitive and more specific than the standard diagnostic tests (Enk et al., 2010). This will be a
significant development in schistosome diagnosis, it would greatly increase the ease by which specimen
collections are made and it will increase the accuracy of the diagnosis significantly as has been shown in our
work with S. haematobium.
The success of control strategies requires a simple, easy-to-perform, sensitive and accurate diagnostic test.
However, current diagnostics of all forms of schistosomiasis are insufficient to detect lowintensity asymptomatic and chronic infections. Detection of eggs and surface and/or secreted antigens is prone
to missing low-grade infections (Stothard et al., 2006Krolewiecki et al., 2013), which comprise the majority of
infections particularly adults with long-standing infections and juveniles who have been treated. As the control
programs become more and more effective in reducing the parasite burden in the individual, the issue of
diagnostic sensitivity will become more critical in the assessment of program effectiveness (Ibironke et al., 2011;
Krolewiecki et al., 2013). That is why an accurate and sensitive point of care diagnostic test is needed.
LAMP has already been used for several major NTDs, notably for malaria (Hopkins et al., 2013, Polley et al.,
2013), tuberculosis (Mitarai et al., 2011), toxoplasmosis(Mikita et al., 2013), leishmaniasis (Mikita et al., 2014)
and for schistosome-infected-snails (Hamburger et al., 2013). LAMP is rapid and simple as the reaction can be
done at a constant temperature with only one type of enzyme (Tomita et al., 2008). LAMP is highly specific as it
uses four sets of primers to amplify six target regions of the DNA (Tomita et al., 2008). It also amplifies DNA
fragments independent of the standard thermocycler and electrophoresis and can easily be adapted for clinical
trials. By using LAMP simpler, rapid and specific schistosome DNA-based testing of urine can be employed in the
field for rapid detection of human schistosome parasites. We show that isothermal amplification of schistosome
species-specific DNA is an effective diagnostic procedure and is equal to PCR amplification for both species of
schistosome.
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Appendix A. Supplementary data
The following is Supplementary data to this article:
Supplementary material
Quantitative analysis of two different diagnostic tests on 86 filtered urine sediments collected in Ghana where 0 = negative and 1 = positive.
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